Cetin S, Bayraktar A, Demiroz O, Karabay K, Yalcinkaya E
Anatol J Cardiol. 2024; .
PMID: 38430111
PMC: 11017680.
DOI: 10.14744/AnatolJCardiol.2024.3744.
Guo X, Xing Y, Jin W
Front Endocrinol (Lausanne). 2023; 14:1183586.
PMID: 37152974
PMC: 10160678.
DOI: 10.3389/fendo.2023.1183586.
Liu Z
Diabetes. 2023; 72(3):313-315.
PMID: 36806606
PMC: 10090265.
DOI: 10.2337/dbi22-0036.
Yagi K, Imamura T, Tada H, Liu J, Miyamoto Y, Ohbatake A
J Diabetes Investig. 2022; 13(6):1052-1061.
PMID: 35092353
PMC: 9153843.
DOI: 10.1111/jdi.13759.
Takahashi K, Mizukami H, Osonoi S, Takeuchi Y, Kudoh K, Sasaki T
J Diabetes Investig. 2021; 12(12):2149-2161.
PMID: 34032392
PMC: 8668063.
DOI: 10.1111/jdi.13601.
Cutaneous microangiopathy in patients with type 2 diabetes: Impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy.
Sugimoto K, Murakami H, Deguchi T, Arimura A, Daimon M, Suzuki S
J Diabetes Investig. 2019; 10(5):1318-1331.
PMID: 30719863
PMC: 6717820.
DOI: 10.1111/jdi.13020.
Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.
Guo J, Miller R, Costacou T, Follansbee W, Orchard T
J Diabetes Complications. 2018; 32(3):298-304.
PMID: 29366734
PMC: 5820228.
DOI: 10.1016/j.jdiacomp.2017.12.004.
Antioxidative Effects of Natural Products on Diabetic Cardiomyopathy.
Yan B, Ren J, Zhang Q, Gao R, Zhao F, Wu J
J Diabetes Res. 2017; 2017:2070178.
PMID: 29181412
PMC: 5664314.
DOI: 10.1155/2017/2070178.
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.
Barrett E, Liu Z, Khamaisi M, King G, Klein R, Klein B
J Clin Endocrinol Metab. 2017; 102(12):4343-4410.
PMID: 29126250
PMC: 5718697.
DOI: 10.1210/jc.2017-01922.
The number of microvascular complications is associated with an increased risk for severity of periodontitis in type 2 diabetes patients: Results of a multicenter hospital-based cross-sectional study.
Nitta H, Katagiri S, Nagasawa T, Izumi Y, Ishikawa I, Izumiyama H
J Diabetes Investig. 2017; 8(5):677-686.
PMID: 28129466
PMC: 5583958.
DOI: 10.1111/jdi.12633.
A Thin Left Atrial Antral Wall Around the Pulmonary Vein Reflects Structural Remodeling by Atrial Fibrillation and is Associated with Stroke.
Park J, Park C, Uhm J, Pak H, Lee M, Joung B
Yonsei Med J. 2017; 58(2):282-289.
PMID: 28120557
PMC: 5290006.
DOI: 10.3349/ymj.2017.58.2.282.
Microcirculatory dysfunction and tissue oxygenation in critical illness.
Ostergaard L, Granfeldt A, Secher N, Tietze A, Iversen N, Jensen M
Acta Anaesthesiol Scand. 2015; 59(10):1246-59.
PMID: 26149711
PMC: 4758388.
DOI: 10.1111/aas.12581.
The role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart disease.
Ostergaard L, Kristiansen S, Angleys H, Frokiaer J, Hasenkam J, Jespersen S
Basic Res Cardiol. 2014; 109(3):409.
PMID: 24743925
PMC: 4013440.
DOI: 10.1007/s00395-014-0409-x.
Role of microangiopathy in diabetic cardiomyopathy.
Adameova A, Dhalla N
Heart Fail Rev. 2013; 19(1):25-33.
PMID: 23456446
DOI: 10.1007/s10741-013-9378-7.
Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease.
Campbell D, Somaratne J, Jenkins A, Prior D, Yii M, Kenny J
Cardiovasc Diabetol. 2011; 10:80.
PMID: 21929744
PMC: 3182888.
DOI: 10.1186/1475-2840-10-80.
The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.
De Freitas O, Lenz O, Fornoni A, Materson B
Vasc Health Risk Manag. 2007; 2(2):139-44.
PMID: 17319457
PMC: 1994002.
DOI: 10.2147/vhrm.2006.2.2.139.
Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging.
Moir S, Hanekom L, Fang Z, Haluska B, Wong C, Burgess M
Heart. 2006; 92(10):1414-9.
PMID: 16606865
PMC: 1861031.
DOI: 10.1136/hrt.2005.079350.
The diabetic myocardium.
Marwick T
Curr Diab Rep. 2006; 6(1):36-41.
PMID: 16522279
DOI: 10.1007/s11892-006-0049-0.
Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.
Al-Shafei A, Wise R, GRESHAM G, Bronns G, Carpenter T, Hall L
J Physiol. 2002; 538(Pt 2):541-53.
PMID: 11790818
PMC: 2290059.
DOI: 10.1113/jphysiol.2001.012856.
A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension.
Kawaguchi M, Techigawara M, Ishihata T, Asakura T, Saito F, Maehara K
Heart Vessels. 1997; 12(6):267-74.
PMID: 9860193
DOI: 10.1007/BF02766802.